Geode Capital Management, LLC Centogene N.V. Transaction History

Geode Capital Management, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 13, 2022	SELL	$3.3 - $5.44 $3 - $5	-1 Reduced 0.01%	11,156 $45,000
Q4 2021 Feb 11, 2022	SELL	$4.56 - $10.56 $45 - $105	-10 Reduced 0.09%	11,157 $57,000
Q2 2021 Aug 13, 2021	SELL	$9.02 - $12.93 $579,093 - $830,118	-64,201 Reduced 85.18%	11,167 $116,000
Q1 2021 May 12, 2021	BUY	$10.56 - $13.94 $6,832 - $9,019	647 Added 0.87%	75,368 $914,000
Q4 2020 Feb 12, 2021	BUY	$9.44 - $13.3 $113,289 - $159,613	12,001 Added 19.13%	74,721 $805,000
Q3 2020 Nov 13, 2020	BUY	$9.3 - $25.16 $344,509 - $932,027	37,044 Added 144.27%	62,720 $593,000
Q2 2020 Aug 13, 2020	BUY	$15.99 - $22.88 $410,559 - $587,466	25,676 New	25,676 $587,000

33.6K

Ticker CNTG
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 27,081,600
Market Cap $2.98M
Description
Centogene N.V., together with its subsidiaries, focuses on rare diseases that transforms real-world clinical and genetic, or other data into actionable information for patients, physicians, and pharmaceutical companies worldwide. It operates through three segments: Pharmaceutical, Diagnostics, and COVID-19 testing. The company develops rare dise...

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Geode Capital Management, LLC with notifications on news.